Browsing Tag
blood cancer innovations
1 post
FDA approves RYTELO by Geron for myelodysplastic syndromes
Geron Corporation (Nasdaq: GERN), a pioneering biopharmaceutical company focused on changing the course of blood cancer treatment, has…